Neuroscience Discovery Chemistry, Research and Development, Bristol-Myers Squibb Company, Wallingford, CT 06492, USA.
Bioorg Med Chem Lett. 2010 Mar 15;20(6):1890-4. doi: 10.1016/j.bmcl.2010.01.129. Epub 2010 Feb 1.
A series of N(3)-pyridylpyrazinones was investigated as corticotropin-releasing factor-1 receptor antagonists. It was observed that the binding affinity of analogues containing a pyridyl group was influenced not only by the substitution pattern on the pyridyl group, but also by the pK(a) of the pyridyl nitrogen. Analogues containing a novel 6-(difluoromethoxy)-2,5-dimethylpyridin-3-amine group were among the most potent N(3)-pyridylpyrazinones synthesized. The synthesis and SAR of N(3)-pyridylpyrazinones is described herein.
研究了一系列 N(3)-吡啶基吡嗪酮作为促肾上腺皮质激素释放因子-1 受体拮抗剂。结果表明,含有吡啶基的类似物的结合亲和力不仅受到吡啶基取代模式的影响,还受到吡啶氮 pk(a)的影响。含有新型 6-(二氟甲氧基)-2,5-二甲基-3-氨基吡啶基的类似物是合成的最有效 N(3)-吡啶基吡嗪酮之一。本文描述了 N(3)-吡啶基吡嗪酮的合成和 SAR。